跳至主要内容
临床试验/NCT00747448
NCT00747448已完成不适用

CryoSpray Ablation (TM) GI Patient Registry

CSA Medical, Inc.6 个研究点 分布在 1 个国家目标入组 199 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
199
试验地点
6
主要终点
Primary objectives of the study are to enable analysis of patient outcomes 2 years after final treatment and report on the effectiveness of the device in eradicating, decreasing or downgrading of the lesions.

研究概览

简要总结

The purpose of this study is to create a patient registry to collect and analyze post-510K approval information on subjects treated endoscopically with the CryoSpray Ablation™ System.

详细描述

The proposed registry is a prospective, multi-center study of patients that are being currently undergoing CryoSpray Ablation™. It will also be used to catalogue retrospective data from records of patients already treated with the device. A maximum of 40 investigational sites will participate in this study.

研究设计

研究类型
Observational
观察模型
Case Only

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The study population consists of patients who are being treated, or were treated, with the CryoSpray Ablation™ System for malignant or pre-malignant conditions of the esophagus, including:
  • Barrett's esophagus with or without dysplasia
  • Squamous dysplasia of the esophagus
  • Esophageal cancer, any stage

排除标准

  • Subjects with esophageal lesions whose pathology was not one of the above.
  • Subjects with one of the above conditions who were not treated with the CryoSpray Ablation™ System.

结局指标

主要结局

Primary objectives of the study are to enable analysis of patient outcomes 2 years after final treatment and report on the effectiveness of the device in eradicating, decreasing or downgrading of the lesions.

时间窗: 2 years post treatment

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

CryoSpray Ablation (TM) GI Patient Registry | 临床试验